Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral PG-116800 Following a Heart Attack

NCT00067236 is registered in ClinicalTrials.gov with Procter and Gamble as lead sponsor.

NCT NCT00067236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00067236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral PG-116800 Following a Heart Attack
Lead sponsor
Procter and Gamble
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2003
Completion date
December 31, 2004
Enrollment
253 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

heart enlargement, heart failure, myocardial infarction